Aaron E. Sosa

520 total citations
13 papers, 275 citations indexed

About

Aaron E. Sosa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Aaron E. Sosa has authored 13 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Aaron E. Sosa's work include Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). Aaron E. Sosa is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). Aaron E. Sosa collaborates with scholars based in Spain, Italy and Mexico. Aaron E. Sosa's co-authors include Niki Karachaliou, Rafael Rosell, Jordi Berenguer, Masaoki Ito, Jillian Wilhelmina Paulina Bracht, Miguel Caballero, Chiara Lazzari, Alberto Verlicchi, Verónica Pereira and Juan J. Grau and has published in prestigious journals such as Head & Neck, Annals of Otology Rhinology & Laryngology and Expert Opinion on Investigational Drugs.

In The Last Decade

Aaron E. Sosa

13 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron E. Sosa Spain 8 194 85 84 48 31 13 275
Adam Diehl United States 7 221 1.1× 54 0.6× 69 0.8× 54 1.1× 36 1.2× 16 299
Grégoire Marret France 8 119 0.6× 96 1.1× 74 0.9× 31 0.6× 27 0.9× 24 231
Nooshin Hashemi Sadraei United States 10 199 1.0× 130 1.5× 66 0.8× 60 1.3× 42 1.4× 30 321
Miao Huang China 9 184 0.9× 61 0.7× 159 1.9× 50 1.0× 23 0.7× 17 298
Antonino Scimone Italy 9 221 1.1× 72 0.8× 165 2.0× 18 0.4× 45 1.5× 22 327
Hilary S. Serracino United States 6 189 1.0× 65 0.8× 96 1.1× 65 1.4× 61 2.0× 9 334
Linpeng Zheng China 10 207 1.1× 77 0.9× 150 1.8× 37 0.8× 23 0.7× 17 304
Daniel S. Bradford United States 8 260 1.3× 57 0.7× 234 2.8× 65 1.4× 19 0.6× 12 373
Sanjeev Deva New Zealand 9 179 0.9× 64 0.8× 60 0.7× 64 1.3× 20 0.6× 37 249
Jiewen Peng China 10 206 1.1× 53 0.6× 103 1.2× 35 0.7× 45 1.5× 19 331

Countries citing papers authored by Aaron E. Sosa

Since Specialization
Citations

This map shows the geographic impact of Aaron E. Sosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron E. Sosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron E. Sosa more than expected).

Fields of papers citing papers by Aaron E. Sosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron E. Sosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron E. Sosa. The network helps show where Aaron E. Sosa may publish in the future.

Co-authorship network of co-authors of Aaron E. Sosa

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron E. Sosa. A scholar is included among the top collaborators of Aaron E. Sosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron E. Sosa. Aaron E. Sosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sosa, Aaron E., et al.. (2018). Clinical assessment of immune-related adverse events. Therapeutic Advances in Medical Oncology. 10. 3861379668–3861379668. 105 indexed citations
2.
Buxó, Elvira, Aaron E. Sosa, Òscar Reig, et al.. (2018). Intravenous 5-Fluorouracil in Patients With Advanced Squamous Cell Carcinoma: A Retrospective Study. Annals of Otology Rhinology & Laryngology. 127(7). 456–462. 2 indexed citations
3.
Karachaliou, Niki, Aaron E. Sosa, Jordi Berenguer, et al.. (2017). The combination of checkpoint immunotherapy and targeted therapy in cancer. Annals of Translational Medicine. 5(19). 388–388. 54 indexed citations
4.
Karachaliou, Niki, et al.. (2017). Possible application of circulating free tumor DNA in non-small cell lung cancer patients. Journal of Thoracic Disease. 9(S13). S1364–S1372. 12 indexed citations
5.
Karachaliou, Niki, Aaron E. Sosa, Feliciano Barrón, et al.. (2017). Pharmacological management of relapsed/refractory NSCLC with chemical drugs. Expert Opinion on Pharmacotherapy. 18(3). 295–304. 11 indexed citations
6.
Karachaliou, Niki, Aaron E. Sosa, Mariacarmela Santarpía, et al.. (2017). Using genetics to predict patient response to platinum-based chemotherapy. Expert Review of Precision Medicine and Drug Development. 2(1). 21–32. 6 indexed citations
7.
Karachaliou, Niki, Aaron E. Sosa, & R. Rosell. (2017). Immunotherapy for small-cell lung cancer: rationale and clinical evidence. 2. 3–3. 1 indexed citations
8.
Karachaliou, Niki, Mariacarmela Santarpía, María González Cao, et al.. (2017). Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer. Expert Opinion on Investigational Drugs. 26(6). 713–722. 16 indexed citations
9.
Rosell, R., Niki Karachaliou, Aaron E. Sosa, & Santiago Viteri. (2016). Immune checkpoint blockade (ICB) for first line treatment in non-small-cell lung cancer (NSCLC). Translational Cancer Research. 3(5). 1 indexed citations
10.
Karachaliou, Niki, Chiara Lazzari, Alberto Verlicchi, Aaron E. Sosa, & Rafael Rosell. (2016). HER3 as a Therapeutic Target in Cancer. BioDrugs. 31(1). 63–73. 25 indexed citations
11.
Rosell, Rafael, Niki Karachaliou, Aaron E. Sosa, & Santiago Viteri. (2016). Immune checkpoint blockade (ICB) for first line treatment in non-small cell lung cancer (NSCLC). Translational Cancer Research. 5(S3). S408–S410. 3 indexed citations
12.
Sosa, Aaron E., et al.. (2013). Outcome of patients treated with palliative weekly Paclitaxel plus Cetuximab in recurrent head and neck cancer after failure of platinum-based therapy. European Archives of Oto-Rhino-Laryngology. 271(2). 373–378. 26 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Diehl Breakdown of academic impact, for papers by Grégoire Marret Breakdown of academic impact, for papers by Nooshin Hashemi Sadraei Breakdown of academic impact, for papers by Miao Huang Breakdown of academic impact, for papers by Antonino Scimone Breakdown of academic impact, for papers by Hilary S. Serracino Breakdown of academic impact, for papers by Linpeng Zheng Breakdown of academic impact, for papers by Daniel S. Bradford Breakdown of academic impact, for papers by Sanjeev Deva Breakdown of academic impact, for papers by Jiewen Peng
Rankless by CCL
2026